Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.
Also called NCT04737265
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 1/2
- Enrolled
- 108 participants
- Registry
-
NCT04737265
-
- Other papers using this trial's data
- Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04737265. Randomized; no masking; primary purpose prevention. Start 2021-03-18 (actual); primary completion 2025-02-05 (actual). Results posted on 2026-06-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
- Acronym
- NTproBNP-Guide
- Condition
- Cardiotoxicity
- Condition
- Toxicity Due to Chemotherapy
- Condition
- Breast Cancer
- Condition
- Lymphoma
- Condition
- Cardiomyopathies
- Condition
- Heart Failure
- Intervention (Other)
- Biomarker Guided Intervention
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct04737265- Content hash
6b77f80ceea3aa95fee29aa98a0d04f17363e757248eddfa43bc1c3d4f74061e